Viewing Study NCT00474734



Ignite Creation Date: 2024-05-05 @ 5:31 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00474734
Status: UNKNOWN
Last Update Posted: 2007-05-17
First Post: 2007-05-15

Brief Title: Intravascular Ultrasound for Hepatocellular Carcinoma Staging
Sponsor: University Hospital Geneva
Organization: University Hospital Geneva

Study Overview

Official Title: Intravascular Ultrasound for the Staging of Hepatocellular Carcinoma a Pilot Study
Status: UNKNOWN
Status Verified Date: 2007-05
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To diagnose hepatocellular carcinoma HCC and to determine the extent of the disease a triphasic CT scan or a magnetic resonance imaging are required The characterization of hepatic nodules is more difficult when the HCC lesions have a diameter of less than 2 cm

Since accuracy in the assessment of the number and the size of HCC nodules as well as of the invasion of blood vessels is crucial to determine outcome after liver transplantation due to tumour recurrence there is a need for techniques with a higher definition potential

As a consequence to improve outcome and to optimize organ allocation patients on the liver transplantation waiting list might benefit from intravascular ultrasound as an additional examination to complete the pre-transplant tumour staging process
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None